Summary & Overview
CPT 81234: DMPK Gene Test for DM1 Allele Expansions
CPT code 81234 denotes a molecular diagnostic laboratory test that detects expanded allele sequences in the DMPK gene, commonly used to diagnose myotonic dystrophy type 1. This genetic test carries clinical importance for confirming diagnosis, guiding genetic counseling, and informing care plans for patients with suspected myotonic dystrophy. Nationally, demand for precise genetic testing has increased as molecular methods become standard in neuromuscular diagnostics.
Key payers addressed in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, expected sites of service, and the role of the test in diagnostic workflows. The publication outlines common billing modifiers and service-line considerations, highlights payer coverage patterns where available, and summarizes benchmarking and reimbursement context relevant to laboratories and billing professionals.
The report is written for a national audience and provides practical reference material on coding and clinical application rather than individualized billing advice. Data not available in the input is identified where applicable.
Billing Code Overview
CPT code 81234 describes a laboratory technical procedure to detect changes in the DM1 protein kinase gene (DMPK), typically used to identify abnormal alleles caused by expanded nucleotide sequences. This service is a molecular diagnostic test focused on identifying pathogenic expansions in the DMPK gene associated with myotonic dystrophy type 1.
Service Type: Molecular diagnostic laboratory test (technical component)
Typical Site of Service: Clinical laboratory or reference molecular diagnostics laboratory
Clinical & Coding Specifications
Clinical Context
A 32-year-old adult with progressive distal muscle weakness, myotonia, and a family history of myotonic dystrophy presents to a neuromuscular clinic. The neurologist orders genetic testing to confirm the diagnosis and to assess the CTG trinucleotide repeat expansion in the DMPK (DM1) gene. A phlebotomy technician collects a peripheral blood sample; the specimen is sent to the molecular diagnostics laboratory. A lab analyst performs the technical testing using PCR and/or Southern blot or triplet-primed PCR methods to detect expanded alleles in the DMPK gene. Results are reviewed by a laboratory director and reported to the ordering clinician. Counseling by a genetic counselor or neurologist follows to explain implications for prognosis, reproductive risk, and cascade family testing.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing for the interpretation/reporting portion performed by a physician or laboratory director separate from the technical testing. |
TC | Technical component | Use when billing only for the laboratory technical testing and not the professional interpretation. |